|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qian L, Li Q, Kwaku B, Qiu W, Li K, Zhang
J, Yu Q, Xu D, Liu W, Brand RE, et al: Biosensors for early
diagnosis of pancreatic cancer: A review. Transl Res. 213:68–89.
2019. View Article : Google Scholar
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park J, Choi Y, Namkung J, Yi SG, Kim H,
Yu J, Kim Y, Kwon MS, Kwon W, Oh DY, et al: Diagnostic performance
enhancement of pancreatic cancer using proteomic multimarker panel.
Oncotarget. 8:93117–93130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akamatsu M, Makino N, Ikeda Y, Matsuda A,
Ito M, Kakizaki Y, Saito Y, Ishizawa T, Kobayashi T, Furukawa T and
Ueno Y: Specific MAPK-Associated MicroRNAs in serum differentiate
pancreatic cancer from autoimmune pancreatitis. PLoS One.
11:e01586692016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu H, Li B, Li T, Zhang S and Lin X:
Combination of noninvasive methods in diagnosis of infertile women
with minimal or mild endometriosis, a retrospective study in China.
Medicine (Baltimore). 98:e166952019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng H and Bai L: Hypoxia induced
microRNA-301b-3p overexpression promotes proliferation, migration
and invasion of prostate cancer cells by targeting LRP1B. Exp Mol
Pathol. 20:1043012019. View Article : Google Scholar
|
|
8
|
Fadaka AO, Pretorius A and Klein A:
Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.
Cancer Control. 26:10732748198627842019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takagawa Y, Gen Y, Muramatsu T, Tanimoto
K, Inoue J, Harada H and Inazawa J: miR-1293, a Candidate for
miRNA-based cancer therapeutics, simultaneously targets BRD4 and
the DNA repair pathway. Mol Ther. 11:pii: S1525-0016. 30182–30189.
2020.
|
|
10
|
Örs Kumoğlu G, Döşkaya M and Gulce Iz S:
The biomarker features of miR-145-3p determined via meta-analysis
validated by qRT-PCR in metastatic cancer cell lines. Gene.
710:341–353. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y
and Li L: MicroRNA-455-3p promotes invasion and migration in triple
negative breast cancer by targeting tumor suppressor EI24.
Oncotarget. 8:19455–19466. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bai X, Lu D, Lin Y, Lv Y and He L: A
seven-miRNA expression-based prognostic signature and its
corresponding potential competing endogenous RNA network in early
pancreatic cancer. Exp Ther Med. 18:1601–1608. 2019.PubMed/NCBI
|
|
13
|
Kooshkaki O, Rezaei Z, Rahmati M, Vahedi
P, Derakhshani A, Brunetti O, Baghbanzadeh A, Mansoori B,
Silvestris N and Baradaran B: MiR-144: A new possible therapeutic
target and diagnostic/prognostic tool in cancers. Int J Mol Sci.
21(pii): E25782020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aggarwal V, Priyanka K and Tuli HS:
Emergence of circulating MicroRNAs in breast cancer as diagnostic
and therapeutic efficacy biomarkers. Mol Diagn Ther. 24:153–173.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Y, Zhao Y, Song X, Song X, Niu L and
Xie L: Tumor-derived exosomal miRNA-320d as a biomarker for
metastatic colorectal cancer. J Clin Lab Anal. 16:e230042019.
|
|
17
|
Munson PB, Hall EM, Farina NH, Pass HI and
Shukla A: Exosomal miR-16-5p as a target for malignant
mesothelioma. Sci Rep. 9:116882019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang
G, Song J, Li Z, Zhang Z and Yuan W: Effect of exosomal miRNA on
cancer biology and clinical applications. Mol Cancer. 17:1472018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu H, Chen X, Ji J, Zhou R, Liu J, Ni W,
Qu L, Ni H, Ni R, Bao B and Xiao M: Progress of exosomes in the
diagnosis and treatment of pancreatic cancer. Genet Test Mol
Biomarkers. 23:215–222. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bortoluzzi S, Lovisa F, Gaffo E and
Mussolin L: Small RNAs in circulating exosomes of cancer patients:
A minireview. High Throughput. 6(pii): E132017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fanale D, Taverna S, Russo A and Bazan V:
Circular RNA in exosomes. Adv Exp Med Biol. 1087:109–117. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jayaseelan VP: Emerging role of exosomes
as promising diagnostic tool for cancer. Cancer Gene Ther. Sep
3–2019.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang W, Yin Y, Shan X, Zhou X, Liu P, Cao
Q, Zhu D, Zhang J and Zhu W: The value of plasma-based MicroRNAs as
diagnostic biomarkers for ovarian cancer. Am J Med Sci.
358:256–267. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He D, Wang H, Ho SL, Chan HN, Hai L, He X,
Wang K and Li HW: Total internal reflection-based single-vesicle in
situ quantitative and stoichiometric analysis of tumor-derived
exosomal microRNAs for diagnosis and treatment monitoring.
Theranostics. 9:4494–4507. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bai H, Lei K, Huang F, Jiang Z and Zhou X:
Exo-circRNAs: A new paradigm for anticancer therapy. Mol Cancer.
18:562019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yi M, Xu L, Jiao Y, Luo S, Li A and Wu K:
The role of cancer-derived microRNAs in cancer immune escape. J
Hematol Oncol. 13:252020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nguyen HV, Gore J, Zhong X, Savant SS,
Deitz-McElyea S, Schmidt CM, House MG and Korc M: MicroRNA
expression in a readily accessible common hepatic artery lymph node
predicts time to pancreatic cancer recurrence postresection. J
Gastrointest Surg. 20:1699–706. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie Y, Hang Y, Wang Y, Sleightholm R,
Prajapati DR, Bader J, Yu A, Tang W, Jaramillo L, Li J, et al:
Stromal modulation and treatment of metastatic pancreatic cancer
with local intraperitoneal triple miRNA/siRNA nanotherapy. ACS
Nano. 14:255–271. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang Z, LaRiviere MJ, Ko J, Till JE,
Christensen T, Yee SS, Black TA, Tien K, Lin A, Shen H, et al: A
multi-analyte panel consisting of extracellular vesicle miRNAs and
mRNAs, cfDNA, and CA19-9 shows utility for diagnosis and staging of
pancreatic adenocarcinoma. Clin Cancer Res. 16:pii: clincanres.
3313:20192020.
|
|
30
|
Yoshizawa N, Sugimoto K, Tameda M, Inagaki
Y, Ikejiri M, Inoue H, Usui M, Ito M and Takei Y:
miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic
biomarker for pancreatic ductal adenocarcinoma. Oncol Lett.
19:2677–2684. 2020.PubMed/NCBI
|
|
31
|
Ko J, Bhagwat N, Black T, Yee SS, Na YJ,
Fisher S, Kim J, Carpenter EL, Stanger BZ and Issadore D: miRNA
profiling of magnetic nanopore-isolated extracellular vesicles for
the diagnosis of pancreatic cancer. Cancer Res. 78:3688–3697.
2018.PubMed/NCBI
|
|
32
|
Matsuda Y, Fujii Y, Matsukawa M, Ishiwata
T, Nishimura M and Arai T: Overexpression of carbohydrate
sulfotransferase 15 in pancreatic cancer stroma is associated with
worse prognosis. Oncol Lett. 18:4100–4105. 2019.PubMed/NCBI
|
|
33
|
Luo G, Javed A, Strosberg JR, Jin K, Zhang
Y, Liu C, Xu J, Soares K, Weiss MJ, Zheng L, et al: Modified
staging classification for pancreatic neuroendocrine tumors on the
basis of the American joint committee on cancer and european
neuroendocrine tumor society systems. J Clin Oncol. 35:274–280.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee YR, Kim G, Tak WY, Jang SY, Kweon YO,
Park JG, Lee HW, Han YS, Chun JM, Park SY and Hur K: Circulating
exosomal noncoding RNAs as prognostic biomarkers in
humanhepatocellular carcinoma. Int J Cancer. 144:1444–1452. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi M, Jiang Y, Yang L, Yan S, Wang YG and
Lu XJ: Decreased levels of serum exosomal miR-638 predict poor
prognosis in hepatocellular carcinoma. J Cell Biochem.
119:4711–4716. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Suehiro T, Miyaaki H, Kanda Y, Shibata H,
Honda T, Ozawa E, Miuma S, Taura N and Nakao K: Serum exosomal
microRNA-122 and microRNA-21 as predictive biomarkers in
transarterial chemoembolization-treated hepatocellular carcinoma
patients. Oncol Lett. 16:3267–3273. 2018.PubMed/NCBI
|
|
37
|
Shiotsu H, Okada K, Shibuta T, Kobayashi
Y, Shirahama S, Kuroki C, Ueda S, Ohkuma M, Ikeda K, Ando Y, et al:
The influence of pre-analytical factors on the analysis of
circulating MicroRNA. Microrna. 7:195–203. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Silverman JM and Reiner NE: Exosomes and
other microvesicles in infection biology: Organelles with
unanticipated phenotypes. Cell Microbiol. 13:1–9. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rahbarghazi R, Jabbari N, Sani NA, Asghari
R, Salimi L, Kalashani SA, Feghhi M, Etemadi T, Akbariazar E,
Mahmoudi M and Rezaie J: Tumor-derived extracellular vesicles:
Reliable tools for Cancer diagnosis and clinical applications. Cell
Commun Signal. 17:732019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Salehi M and Sharifi M: Exosomal miRNAs as
novel cancer biomarkers: Challenges and opportunities. J Cell
Physiol. 233:6370–6380. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang M, Yu F, Ding H, Wang Y, Li P and
Wang K: Emerging function and clinical values of exosomal MicroRNAs
in cancer. Mol Ther Nucleic Acids. 16:791–804. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Capula M, Mantini G, Funel N and
Giovannetti E: New avenues in pancreatic cancer: Exploiting
microRNAs as predictive biomarkers and new approaches to target
aberrant metabolism. Expert Rev Clin Pharmacol. 12:1081–1090. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Taylor DD and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Oncol. 110:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rabinowits G, Gerçel-Taylor C, Day JM,
Taylor DD and Kloecker GH: Exosomal microRNA: A diagnostic marker
for lung cancer. Clin Lung Cancer. 10:42–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sohn W, Kim J, Kang SH, Yang SR, Cho JY,
Cho HC, Shim SG and Paik YH: Serum exosomal microRNAs as novel
biomarkers for hepatocellular carcinoma. Exp Mol Med. 47:e1842015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
de Carvalho IN, de Freitas RM and Vargas
FR: Translating microRNAs into biomarkers: What is new for
pediatric cancer? Med Oncol. 33:492016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Su J, Wu F, Xia H, Wu Y and Liu S:
Accurate cancer cell identification and microRNA silencing induced
therapy using tailored DNA tetrahedron nanostructures. Chem Sci.
11:80–86. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Luo D, Huang Z, Lv H, Wang Y, Sun W and
Sun X: Up-regulation of MicroRNA-21 indicates poor prognosis and
promotes cell proliferation in esophageal squamous cell carcinoma
via upregulation of lncRNA SNHG1. Cancer Manag Res. 12:1–14. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Goto T, Fujiya M, Konishi H, Sasajima J,
Fujibayashi S, Hayashi A, Utsumi T, Sato H, Iwama T, Ijiri M, et
al: An elevated expression of serum exosomal microRNA-191, - 21,
−451a of pancreatic neoplasm is considered to be efficient
diagnostic marker. BMC Cancer. 18:1162018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Feng S, He A, Wang D and Kang B:
Diagnostic significance of miR-210 as a potential tumor biomarker
of human cancer detection: An updated pooled analysis of 30
articles. Onco Targets Ther. 12:479–493. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hong L, Han Y, Zhang H, Zhao Q and Qiao Y:
miR-210: A therapeutic target in cancer. Expert Opin Ther Targets.
17:21–28. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ren CX, Leng RX, Fan YG, Pan HF, Wu CH and
Ye DQ: MicroRNA-210 and its theranostic potential. Expert Opin Ther
Targets. 20:1325–1338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Bavelloni A, Ramazzotti G, Poli A, Piazzi
M, Focaccia E, Blalock W and Faenza I: MiRNA-210: A current
overview. Anticancer Res. 37:6511–6521. 2017.PubMed/NCBI
|
|
56
|
Li W, Liu H, Qian W, Cheng L, Yan B, Han
L, Xu Q, Ma Q and Ma J: Hyperglycemia aggravates microenvironment
hypoxia and promotes the metastatic ability of pancreatic cancer.
Comput Struct Biotechnol J. 16:479–487. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen S, Zhang J, Chen J, Wang Y, Zhou S,
Huang L, Bai Y, Peng C, Shen B, Chen H and Tian Y: RER1 enhances
carcinogenesis and stemness of pancreatic cancer under hypoxic
environment. J Exp Clin Cancer Res. 38:152019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Severino V, Dumonceau JM, Delhaye M, Moll
S, Annessi-Ramseyer I, Robin X, Frossard JL and Farina A:
Extracellular vesicles in bile as markers of malignant biliary
stenoses. Gastroenterology. 153:495–504.e8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang J, Chen J, Chang P, LeBlanc A, Li D,
Abbruzzesse JL, Frazier ML, Killary AM and Sen S: MicroRNAs in
plasma of pancreatic ductal adenocarcinoma patients as novel
blood-based biomarkers of disease. Cancer Prev Res. 2:807–813.
2009. View Article : Google Scholar
|
|
60
|
Qu K, Zhang X, Lin T, Liu T, Wang Z, Liu
S, Zhou L, Wei J, Chang H, Li K, et al: Circulating miRNA-21-5p as
a diagnostic biomarker for pancreatic cancer: Evidence from
comprehensive miRNA expression profiling analysis and clinical
validation. Sci Rep. 7:16922017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kowal J, Arras G, Colombo M, Jouve M,
Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M and Thery
C: Proteomic comparison defines novel markers to characterize
heterogeneous populations of extracellular vesicle subtypes. Proc
Natl Acad Sci USA. 113:E968–E977. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hu Q, Su H, Li J, Lyon C, Tang W, Wan M
and Hu TY: Clinical applications of exosome membrane proteins.
Precis Clin Med. 3:54–66. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Makler A and Asghar W: Exosomal biomarkers
for cancer diagnosis and patient monitoring. Expert Rev Mol Diagn.
20:387–400. 2020. View Article : Google Scholar : PubMed/NCBI
|
